Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Dendritic Cell Cancer Vaccine Market to reach USD 1326.4 million by the end of 2029.

Global Dendritic Cell Cancer Vaccine Market Size study & Forecast, by Products Outlook (CreaVax, Sipuleucel-T and others), By End-use (Pediatrics, Adults) and Regional Analysis, 2022-2029

Product Code: HLSDT-23249760
Publish Date: 24-04-2023
Page: 200

Global Dendritic Cell Cancer Vaccine Market is valued at approximately USD 236.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 12.18% over the forecast period 2022-2029. Dendritic cells (DCs) are an uncommon class of leukocytes. Due to their exceptional effectiveness in presenting antigens to T cells, they have recently been applied to therapeutic cancer vaccinations. Experimental animals are found to develop both preventive and curative anti-tumor immunity after receiving isolated DCs that have been ex vivo loaded with tumor antigens and delivered as a cellular vaccine. The market is expanding because of significant factors such as the rise in the demand for cancer vaccines and increasing healthcare expenditure as well as research.t.

According to the GLOBOCAN 2020 report, which was released by the International Agency for Research on Cancer and estimated the incidence and mortality of 36 cancers in 185 countries worldwide, there were reportedly 19,292,789 new cases of cancer diagnosed in 2020 and roughly 9,958,133 cancer-related deaths worldwide. Males made up 10,065,305 of the total diagnosed cases of cancer, while females made up 9,227,484 of those cases. By 2040, it was predicted that there will be 15,585,096 cases of cancer in men and 13,302,846 in women. The prevalence of cancer in the world’s population is anticipated to fuel market expansion. Additionally, in November 2020, Moderna Inc. reported interim data from the expansion cohort of its ongoing Phase 1 research using Merck’s Keytruda and its mRNA personalized cancer vaccine (PCV), mRNA-4157. The findings showed that the vaccine candidate is well tolerated at all dose levels and produced responses as indicated by tumour shrinkage in HPV-negative head and neck squamous cell carcinoma (HNSCC) patients. However, potential Side Effects Caused by Cancer Vaccines and Low accessibility to vaccines in remote areas stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dendritic Cell Cancer Vaccine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share globally owing to the rise in the incidence of cancer cases and extensive research studies sponsored by academic research institutes and pharmaceutical giants. On the other side, Europe is expected to be the fastest growing region due to the rising incidence of cancer, the rise in support for research studies from cancer societies across Europe, and emerging market players in the region positively impacting the growth of the dendritic cell cancer vaccine market.

Major market player included in this report are:
ImmunoCellular Therapeutics Ltd
GlaxoSmithKline plc,
3M Company
Activartis Biotech GmbH
DanDrit Biotech A/S
Batavia Bioservices
Argos Therapeutics
Sanpower Group
Elios Therapeutics

Recent Developments in the Market:
Ø Medigene and BioNTech have partnered to collaborate on the development of T-cell immunotherapies that target several solid tumour sites. Under the partnership, Medigene’s preclinical T-cell receptors (TCR) initiatives, which employ Medigene’s switch-receptor technology for the creation of TCR treatments and dendritic cell vaccines, will be acquired by BioNTech.

Global Dendritic Cell Cancer Vaccine Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Outlook, End Use Outlook, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Outlook:
Sipuleucel-T (Provenge)
By End Use Outlook:

By Region:
North America
Asia Pacific
South Korea
Latin America
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Dendritic Cell Cancer Vaccine Market, by region, 2019-2029 (USD Million)
1.2.2. Dendritic Cell Cancer Vaccine Market, by Product Outlook, 2019-2029 (USD Million)
1.2.3. Dendritic Cell Cancer Vaccine Market, by Application, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Dendritic Cell Cancer Vaccine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Dendritic Cell Cancer Vaccine Market Dynamics
3.1. Dendritic Cell Cancer Vaccine Market Impact Analysis (2019-2029)
3.1.1. Market Drivers Rise In The Demand For Cancer Vaccines Increasing Healthcare Expenditure and Research Support
3.1.2. Market Challenges Potential Side Effects Caused by Cancer Vaccines Low accessibility to vaccines in remote areas
3.1.3. Market Opportunities Increased funding for Research and development
Chapter 4. Global Dendritic Cell Cancer Vaccine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Dendritic Cell Cancer Vaccine Market, by Product Outlook
6.1. Market Snapshot
6.2. Global Dendritic Cell Cancer Vaccine Market by Product Outlook, Performance – Potential Analysis
6.3. Global Dendritic Cell Cancer Vaccine Market Estimates & Forecasts by Product Outlook 2019-2029 (USD Million)
6.4. Dendritic Cell Cancer Vaccine Market, Sub Segment Analysis
6.4.1. CreaVax
6.4.2. Sipuleucel-T (Provenge)
6.4.3. Other
Chapter 7. Global Dendritic Cell Cancer Vaccine Market, by End Use Outlook
7.1. Market Snapshot
7.2. Global Dendritic Cell Cancer Vaccine Market by End Use Outlook, Performance – Potential Analysis
7.3. Global Dendritic Cell Cancer Vaccine Market Estimates & Forecasts by End Use Outlook 2019-2029 (USD Million)
7.4. Dendritic Cell Cancer Vaccine Market, Sub Segment Analysis
7.4.1. Pediatrics
7.4.2. Adults
Chapter 8. Global Dendritic Cell Cancer Vaccine Market, Regional Analysis
8.1. Dendritic Cell Cancer Vaccine Market, Regional Market Snapshot
8.2. North America Dendritic Cell Cancer Vaccine Market
8.2.1. U.S. Dendritic Cell Cancer Vaccine Market Product Outlook breakdown estimates & forecasts, 2019-2029 End Use Outlook breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Dendritic Cell Cancer Vaccine Market
8.3. Europe Dendritic Cell Cancer Vaccine Market Snapshot
8.3.1. U.K. Dendritic Cell Cancer Vaccine Market
8.3.2. Germany Dendritic Cell Cancer Vaccine Market
8.3.3. France Dendritic Cell Cancer Vaccine Market
8.3.4. Spain Dendritic Cell Cancer Vaccine Market
8.3.5. Italy Dendritic Cell Cancer Vaccine Market
8.3.6. Rest of Europe Dendritic Cell Cancer Vaccine Market
8.4. Asia-Pacific Dendritic Cell Cancer Vaccine Market Snapshot
8.4.1. China Dendritic Cell Cancer Vaccine Market
8.4.2. India Dendritic Cell Cancer Vaccine Market
8.4.3. Japan Dendritic Cell Cancer Vaccine Market
8.4.4. Australia Dendritic Cell Cancer Vaccine Market
8.4.5. South Korea Dendritic Cell Cancer Vaccine Market
8.4.6. Rest of Asia Pacific Dendritic Cell Cancer Vaccine Market
8.5. Latin America Dendritic Cell Cancer Vaccine Market Snapshot
8.5.1. Brazil Dendritic Cell Cancer Vaccine Market
8.5.2. Mexico Dendritic Cell Cancer Vaccine Market
8.6. Rest of The World Dendritic Cell Cancer Vaccine Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. ImmunoCellular Therapeutics Ltd Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.2.2. GlaxoSmithKline plc,
9.2.3. 3M Company
9.2.4. Activartis Biotech GmBH
9.2.5. DanDrit Biotech A/S
9.2.6. Batavia Bioservices
9.2.7. Argos Therapeutics
9.2.8. Sanpower Corporation
9.2.9. Elios Therapeutics
9.2.10. DCPrime
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now